Marco-Alexander Breit wurde 1981 in Neunkirchen / Saarland geboren. Von 2001 bis 2008 studierte er Politikwissenschaft, Soziologie sowie Mittlere und Neuere Geschichte an der Ruprecht-Karls-Universität Heidelberg sowie Internationale Politische Ökonomie an der Katholischen Universität Leuven / Belgien. Von 2008 bis 2014 hatte er verschiedene Positionen in der Staatskanzlei des Saarlandes inne, darunter Leiter des Büros des Chefs der Staatskanzlei und Ministers für Bund, Kultur und Medien (2010-2011) sowie ab 2011 Leiter des Büros von Ministerpräsidentin Annegret Kramp-Karrenbauer. Ab April 2014 war er als Persönlicher Referent des Chefs des Bundeskanzleramts und Bundesministers für besondere Aufgaben, Peter Altmaier, im Bundeskanzleramt Berlin tätig. Von April 2018 bis Juli 2019 leitete Breit das Referat für Grundsätze der Digitalpolitik und Koordinierung im Bundeswirtschaftsministerium. Seit August 2019 leitet er die Stabstelle Künstliche Intelligenz im Bundesministerium für Wirtschaft und Energie.
Enrico Lyb is a Senior Innovation Architect for the Chronic Care Management Business Line at Siemens Healthineers Japan. In his role he is responsible for driving co-creation projects with customers in the Asia-Pacific region as well as coordinating product development activities between Headquarter and near-shore teams. Prior to his current position, he worked on Innovation projects in the area of Clinical Decision Support after joining Siemens in 2014, by integrating relevant clinical information into the physician’s workflow. He held Software Architecture and Product Development roles for various products in Radiology Imaging, Advanced 3D Visualization, and Healthcare IT with companies in Germany and USA, before he relocated to Japan in 2009. Enrico has over 20 years of experience in the Healthcare industry, working closely with customers and partners to enable better outcomes for patients at lower costs.
Germany Trade and Invest - Gesellschaft für Außenwirtschaft und Standortmarketing mbH Headquarters Friedrichstraße 60 10117 Berlin Germany T. +49 (0)30 200 099-506 F. +49 (0)30 200 099-999 M.: email@example.com www.gtai.com
Germany Trade and Invest - Gesellschaft für Außenwirtschaft und Standortmarketing mbH Headquarters Friedrichstraße 60 10117 Berlin Germany T. +49 (0)30 200 099-235 M.: firstname.lastname@example.org www.gtai.com
Dietmar Frey is a neurosurgeon and the founding director of the Charité Lab for Artificial Intelligence in Medicine. After obtaining a law degree and passing the bar examination in Berlin in 2003 Dietmar went to Charité Medical School. In 2007, he graduated and specialized in the Charité Department of Neurosurgery. He is a certified board member in neurosurgery since 2013. For the last 4 years, he has been working on advancing stroke treatment by personalized data-driven stroke prediction. Funded by several federal grants (€2.5m) he has built a strong interdisciplinary team of physicians, software engineers and computer scientists to develop an AI-based decision support system that provides risk scoring and treatment planning in stroke. In addition, he leads PRECISE4Q, a joint venture of 11 partners in Europe to create data-driven support systems for medicine. It is funded via the Horizon 2020 framework with €5.9m. He just finished an MBA with the University of London at Queen Mary’s College.
The project PREDICTioN 2020 provides AI-based prediction of stroke outcome. An interdisciplinary team of stroke experts, AI-engineers, researchers and developers is dedicated to advance stroke treatment.
Dr Dietmar Frey, MD JD MBA Head of Charité Lab for Artificial Intelligence in Medicine (CLAIM) Project lead PREDICTioN2020 (BMBF) Coordinator PRECISE4Q (Horizon 2020)
Charité University Medicine Charitéplatz 1 10115 Berlin, Germany Tel.: +49-30-450 560398 Fax.: +49-30-450 560900 prediction2020.org / precise4q.eu
Akira Kitamura is General Manager of the AI Drug Development Division under the Business Innovation Unit at NEC Corporation in Tokyo. The division seeks to expand the application of NEC’s cutting-edge AI technologies to cancer drug development that focuses on advanced immunotherapy as part of enhancing its healthcare business. He leads corporate level mid-to-long term new business development initiatives which includes the creation of business cases, raising internal and external funding and conducting market validation. He has a stellar track record in the field of business development where, for instance, he successfully launched a spin-off venture called CYTLIMIC which focuses on the clinical development of therapeutic peptide vaccines. He has also recently completed an acquisition of a Norwegian bioinformatics company, OncoImmunity AS where he is currently serving as the Chairman of the Board.
VSI -Virtual Surgery Intelligence (バーチャル手術のインテリジェンス)
アポクラー（apoQlar） 社 CEO
Sirko Pelzl studied Business Administration across Europe in Hamburg, Leipzig, London and Prague. From 2002 to 2017 he was IT Senior Developer and SAP Software Architect and worked for companies such as Philips, Sony, Audi, EON, Telekom and Bosch. In 2007, he founded the Apollogic Group and was its CTO until 2017, where he was responsible for the technological direction of the company. Since 2017, he has been CEO and CTO of apoQlar GmbH, a global pioneer in medical imaging. The company deals with mixed and augmented reality, as well as data evaluation through artificial intelligence and continuous machine learning.
apoQlar GmbH stands for medical progress and it is a worldwide leader for innovative medical applications. We specialize in the latest technologies, particularly in imaging techniques (mixed and augmented reality) and data evaluation for quality assurance by artificial intelligence and continuous machine learning. The applications are developed and implemented in close cooperation with research institutes, clinics, hospitals, and doctors.
VSI Evolving Hospital is a complete and functional system which covers all medical fields and processes, making them digital, safer, and more efficient. It is continually developed with involvement of the medical staff, the patients, and the IT. VSI will be seamlessly integrated into the existing hospital infrastructure. From surgical plannings to documentation, from patient education to patient rounds, from telesurgery to training; all these processes and more are digitalized and optimized by VSI. It is an enormous improvement in working conditions, increases patient safety and care, and guarantees optimal quality. During their daily routines the doctors and staff will use the VSI – Virtual Surgery Intelligence running on the mixed reality glasses HoloLens. They will see virtual 3D Holograms of important patient information, prepared by AI, such as lab results, MRI/CT scans, surgical reports etc., in real space in front of them. With voice commands these can easily be toggled to allow the wearer full control. VSI is defined by doctors for doctors, and with their help, continually improved and developed. Each and every hospital’s requirements are considered, allowing them to shape the future of their internal processes exactly the way they want them.
Inga Bergen is Managing Director of Magnosco GmbH, the Berlin based start-up has developed a non invasive skin cancer diagnostic procedure, using laser technology and AI. Inga Bergen has many years of expertise in the healthcare sector: As managing director, she has established welldoo GmbH as one of the leading digital service providers in the healthcare market. In addition to her role as Managing Director of Magnosco, Inga Bergen is currently spokeswoman for the Advisory Council on Ethics and Digital Transformation at AOK North East. She is also ambassador for health 4.0 in the health cluster Berlin-Brandenburg.
ご経歴 Bjol joined FiNC in 2019 to help bring the company to Europe. Prior to joining FiNC in his current role, he engaged in doctoral studies on organisational culture in startups at the University of Oxford, St Antony`s College. Prior to this, he was active at Fuller, Inc., a Japanese app data startup, where he had a similar role. He started his professional career outside of business and was active as a classical concert pianist before entering the startup space.
FiNC Technologies Inc. (FiNC) creates solutions to deliver health & wellness recommendations to help people form, maintain and enjoy healthy lifestyle habits. Based on an analysis of biometrics, preferences and behaviors, FiNC empowers users to see, understand and change how daily habits affect their health. Lifestyle factors such as diet, exercise, sleep and stress are digitized and monitored through the use of wearable devices, diagnostic kits and surveys in order to provide personalized recommendations for each individual user.
With over 4 million downloads in Japan, the FiNC App is an intuitive way to track health and receive advice on how to improve lifestyle habits. A chatbot serves as a personal coach for each user, summarizing activities, asking questions to collect relevant data and providing recommendations. A social network within the app creates a community dynamic which drives the discovery of other’s lifestyles, products and people, encouraging behavioral change. FiNC App has continuously ranked #1 in gross downloads in the health & fitness category for Japan’s Appstore.
All rights reserved. Any reproduction in whole or part only with express written permission. All efforts are made to ensure integrity of the content, however we are not liable for any mistakes that may occur.